June 13 (Reuters) - Eli Lilly & Co said on Wednesday its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year.


60


Reuters

Latest News

BBC: Manchester United v Derby County

Los Angeles Times: Brett Kavanaugh goes on TV, demanding fairness. But fairness to whom, exactly?

Daily Mail: Video: Man jumps off a bridge with a carton of tins

Daily Mail: Angels' Briceno beats Rangers with 11th-inning HR

Daily Mail: Cosby's day of reckoning comes after 3-year sex assault...

Daily Mail: A's clinch playoff berth, then beat Mariners 7-3

Reuters: UPDATE 5-Instagram co-founders resign in latest Facebook executive exit

Reuters: GLOBAL MARKETS-Stocks struggle as US-China trade row revives growth concerns; oil elevated

Reuters: Stocks struggle as U.S.-China trade row revives growth concerns; oil elevated

Ynet: UK PM May to meet Iran's Rouhani

FOX: Kavanaugh is short of votes, but fate hinges on upcoming testimony

FOX: UN to caution against populism in high-level week

FOX: Viral video shows man trying to bathe feet in Yellowstone's thermal hot springs: report

ABC: Asian stocks mixed on US-China trade worries

Los Angeles Times: Dodgers rally in seventh to move one game closer to postseason

Daily Mail: Victoria's finest renew rivalry in FFA Cup

Daily Mail: Camilla Franks' fiance JP Jones kisses fashion designer as she finishes chemotherapy

Daily Mail: Dodgers rally, hold onto slim lead in West

Daily Mail: A's club 4 homers, overpower Mariners

Daily Mail: Stocks struggle as US-China trade row revives growth...

Daily Mail: Briceno's walk-off HR sends Angels past Rangers 5-4 in 11

Daily Mail: Asian stocks mixed on US-China trade worries

Daily Mail: No respite for relatives of Ethiopia's disappeared

15 Related Articles, between 2018-05-14 and 2018-05-10